Margaret Karow

9.2k citations

35 papers · 5.7k indexed · 3 hit papers · h-index 27

Immunology top 0.5%
Molecular Biology top 5%
Epidemiology top 2%
Physiology top 2%
Genetics top 2%

Co-authors: George D. Yancopoulos David M. Valenzuela Andrew Murphy Richard A. Flavell Niels C. Adams Akiko Iwasaki Lena Alexopoulou Jennifer M. Lund
Topics: Bacterial Genetics and Biotechnology (10 papers)RNA and protein synthesis mechanisms (6 papers)Monoclonal and Polyclonal Antibodies Research (5 papers)
Cited by: Geriatrics and Gerontology Immunology Immunology and Allergy
Journals: Cell Proceedings of the National Academy of Sciences Circulation
Partner nations: United States France Switzerland

In The Last Decade

Margaret Karow

35 papers receiving 5.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Recognition of single-stranded RNA viruses by Toll-like receptor 7

2004 1.4k citations Margaret Karow, Richard A. Flavell et al. profile →
SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cells

2006 930 citations Marcia C. Haigis, Raúl Mostoslavsky et al. Cell profile →
Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammation

2007 522 citations Lauren A. Zenewicz, George D. Yancopoulos et al. Immunity profile →

Peers

Countries citing papers authored by Margaret Karow

Since Specialization

Citations

This map shows the geographic impact of Margaret Karow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Margaret Karow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Margaret Karow more than expected).

Fields of papers citing papers by Margaret Karow

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Margaret Karow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Margaret Karow. The network helps show where Margaret Karow may publish in the future.

Co-authorship network of co-authors of Margaret Karow

This figure shows the co-authorship network connecting the top 25 collaborators of Margaret Karow. A scholar is included among the top collaborators of Margaret Karow based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Margaret Karow. Margaret Karow is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	XTX101, a tumor-activated, Fc-enhanced anti-CTLA-4 monoclonal antibody, demonstrates tumor-growth inhibition and tumor-selective pharmacodynamics in mouse models of cancer 2023 ·Journal for ImmunoTherapy of Cancer ·(unknown),Miso Park,Magali Pederzoli-Ribeil,Uğur Eskiocak,(unknown),(unknown),M. A. McLaughlin,(unknown),(unknown),Zhen Liu,Benjamin Nicholson,(unknown),Huawei Qiu,Tim Clackson,Rónán C. O’Hagan,Ulrich Rodeck,Margaret Karow,Jennifer O’Neil,John C. Williams	8
2	587 Tumor-activated Fc-engineered anti-CTLA-4 monoclonal antibody, XTX101, demonstrates tumor-selective PD and efficacy in preclinical models 2020 ·SHILAP Revista de lepidopterología ·(unknown),(unknown),Minjie Zhang,(unknown),Uğur Eskiocak,M. A. McLaughlin,(unknown),Magali Pederzoli-Ribeil,Miso Park,John C. Williams,Margaret Karow,Jennifer O’Neil,Timothy Piers Clackson,Rónán C. O’Hagan	2
3	Evolution and Emergence of Therapeutic Monoclonal Antibodies 2013 ·Circulation ·Ian N. Foltz,Margaret Karow,Scott M. Wasserman	70
4	Mice completely lacking immunoproteasomes show major changes in antigen presentation 2011 ·Nature Immunology ·Eleanor Kincaid,(unknown),Ian A. York,Hernando Escobar,Eduardo Reyes‐Vargas,Julio C. Delgado,Raymond M. Welsh,Margaret Karow,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Kenneth L. Rock	218
5	Interleukin-19 Is a Negative Regulator of Innate Immunity and Critical for Colonic Protection 2010 ·Journal of Pharmacological Sciences ·Yasu‐Taka Azuma,Yukiko Matsuo,Hidemitsu Nakajima,George D. Yancopoulos,David M. Valenzuela,Andrew Murphy,Margaret Karow,Tadayoshi Takeuchi	27
6	Interleukin-19 protects mice from innate-mediated colonic inflammation 2009 ·Inflammatory Bowel Diseases ·Yasu‐Taka Azuma,Yukiko Matsuo,Mitsuru Kuwamura,George D. Yancopoulos,David M. Valenzuela,Andrew Murphy,Hidemitsu Nakajima,Margaret Karow,Tadayoshi Takeuchi	97
7	Interleukin-22 but Not Interleukin-17 Provides Protection to Hepatocytes during Acute Liver Inflammationbreakdown → 2007 ·Immunity ·Lauren A. Zenewicz,George D. Yancopoulos,David M. Valenzuela,Andrew Murphy,Margaret Karow,Richard A. Flavell	522
8	Resistin-like molecule-β is an allergen-induced cytokine with inflammatory and remodeling activity in the murine lung 2007 ·American Journal of Physiology-Lung Cellular and Molecular Physiology ·Anil Mishra,Meiqin Wang,(unknown),Nikolaos M. Nikolaidis,Charles DeBrosse,Margaret Karow,Marc E. Rothenberg	57
9	Cutting Edge: IL-23 Cross-Regulates IL-12 Production in T Cell-Dependent Experimental Colitis 2006 ·The Journal of Immunology ·Christoph Becker,Heike Dornhoff,Clemens Neufert,Massimo Claudio Fantini,Stefan Wirtz,(unknown),Alexei Nikolaev,Hans‐Anton Lehr,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Peter R. Galle,Margaret Karow,Markus F. Neurath	186
10	Resistin-like molecule β regulates innate colonic function: Barrier integrity and inflammation susceptibility 2006 ·Journal of Allergy and Clinical Immunology ·Simon P. Hogan,Luqman Seidu,Carine Blanchard,Katherine Groschwitz,Anil Mishra,Margaret Karow,Richard Ahrens,David Artis,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Marc E. Rothenberg	131
11	IL-23 cross-regulates IL-12 production in T cell dependent experimental colitis 2006 ·Zeitschrift für Gastroenterologie ·Christian Becker,Heike Dornhoff,Clemens Neufert,(unknown),Stefan Wirtz,Sabine Hübner,(unknown),(unknown),(unknown),(unknown),(unknown),Peter R. Galle,Margaret Karow,(unknown)	6
12	SIRT4 Inhibits Glutamate Dehydrogenase and Opposes the Effects of Calorie Restriction in Pancreatic β Cellsbreakdown → 2006 ·Cell ·Marcia C. Haigis,Raúl Mostoslavsky,Kevin M. Haigis,Kamau Fahie,Danos C. Christodoulou,Andrew Murphy,David M. Valenzuela,George D. Yancopoulos,Margaret Karow,Gil Blander,Cynthia Wolberger,Tomas A. Prolla,Richard Weindruch,Frederick W. Alt,Leonard Guarente	930
13	The Eotaxin Chemokines and CCR3 Are Fundamental Regulators of Allergen-Induced Pulmonary Eosinophilia 2005 ·The Journal of Immunology ·Samuel M. Pope,Nives Zimmermann,Keith Stringer,Margaret Karow,Marc E. Rothenberg	194
14	Construction of gusA transcriptional fusion vectors for Bacillus subtilis and their utilization for studies of spore formation 1995 ·Gene ·Margaret Karow,Patrick J. Piggot	59
15	The essential Escherichia coli msbA gene, a multicopy suppressor of null mutations in the htrB gene, is related to the universally conserved family of ATP‐dependent translocators 1993 ·Molecular Microbiology ·Margaret Karow,Costa Georgopoulos	124
16	The lethal phenotype caused by null mutations in the Escherichia coli htrB gene is suppressed by mutations in the accBC operon, encoding two subunits of acetyl coenzyme A carboxylase 1992 ·Journal of Bacteriology ·Margaret Karow,Olivier Fayet,Costa Georgopoulos	45
17	Isolation and characterization of the Escherichia coli msbB gene, a multicopy suppressor of null mutations in the high-temperature requirement gene htrB 1992 ·Journal of Bacteriology ·Margaret Karow,Costa Georgopoulos	100
18	Complex phenotypes of null mutations in the htr genes, whose products are essential for Escherichia coli growth at elevated temperatures 1991 ·Research in Microbiology ·Margaret Karow,Satish Raina,Costa Georgopoulos,Olivier Fayet	17
19	Sequencing, mutational analysis, and transcriptional regulation of the Escherichia coli htrB gene 1991 ·Molecular Microbiology ·Margaret Karow,Costa Georgopoulos	43
20	The exuperantia gene is required for Drosophila spermatogenesis as well as anteroposterior polarity of the developing oocyte, and encodes overlapping sex-specific transcripts. 1990 ·Genetics ·Tulle Hazelrigg,W. Scott Watkins,(unknown),Chen Tu,Margaret Karow,Xinhua Lin	32

About Margaret Karow

Margaret Karow is a scholar working on Immunology, Genetics and Parasitology, having authored 35 papers that have together received 5.7k indexed citations. Recurring topics across this work include Bacterial Genetics and Biotechnology (10 papers), RNA and protein synthesis mechanisms (6 papers) and Monoclonal and Polyclonal Antibodies Research (5 papers). The work is most often cited by research in Geriatrics and Gerontology (677 citations), Immunology (2.6k citations) and Immunology and Allergy (261 citations). Margaret Karow has collaborated with scholars based in United States, France and Switzerland. Frequent co-authors include George D. Yancopoulos, David M. Valenzuela, Andrew Murphy, Richard A. Flavell, Niels C. Adams, Akiko Iwasaki, Lena Alexopoulou, Jennifer M. Lund, Ayuko Sato and Costa Georgopoulos. Their work appears in journals such as Cell, Proceedings of the National Academy of Sciences and Circulation.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact